Heme binding to the SARS-CoV-2 spike glycoprotein
Journal of Biological Chemistry · 2023-08 · 299 (8) · 105014
DOI: 10.1016/j.jbc.2023.105014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2023-08. Verfasst von Samuel L Freeman und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry, Cantock's Close, University of Bristol, Bristol, United Kingdom. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK, Wellcome Trust, Biotechnology and Biological Sciences Research Council.
Abstract (Originalsprache)
The target for humoral immunity, SARS-CoV-2 spike glycoprotein, has become the focus of vaccine research and development. Previous work demonstrated that the N-terminal domain (NTD) of SARS-CoV-2 spike binds biliverdin-a product of heme catabolism-causing a strong allosteric effect on the activity of a subset of neutralizing antibodies. Herein, we show that the spike glycoprotein is also able to bind heme (KD = 0.5 ± 0.2 μM). Molecular modeling indicated that the heme group fits well within the same pocket on the SARS-CoV-2 spike NTD. Lined by aromatic and hydrophobic residues (W104, V126, I129, F192, F194, I203, and L226), the pocket provides a suitable environment to stabilize the hydrophobic heme. Mutagenesis of N121 has a substantive effect on heme binding (KD = 3000 ± 220 μM), confirming the pocket as a major heme binding location of the viral glycoprotein. Coupled oxidation experiments in the presence of ascorbate indicated that the SARS-CoV-2 glycoprotein can catalyze the slow conversion of heme to biliverdin. The heme trapping and oxidation activities of the spike may allow the virus to reduce levels of free heme during infection to facilitate evasion of the adaptive and innate immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemistry, Cantock's Close, University of Bristol, Bristol, United Kingdom.
- Chromatin Structure and Mobile DNA Laboratory, The Francis Crick Institute, London, United Kingdom.
- Chromatin Structure and Mobile DNA Laboratory, The Francis Crick Institute, London, United Kingdom; Department of Infectious Disease, St-Mary's Campus, Imperial College London, United Kingdom. Electronic address: Peter.…
- School of Chemistry, Cantock's Close, University of Bristol, Bristol, United Kingdom. Electronic address: emma.raven@bristol.ac.uk.
Förderung
- Cancer Research UK
- Wellcome Trust
- Biotechnology and Biological Sciences Research Council
- Medical Research Council
- British Heart Foundation
- Horizon 2020 Framework Programme
- Engineering and Physical Sciences Research Council
- European Research Council
Zitieren
APA
Freeman, S. L., Oliveira, A. S. F., Gallio, A. E., Rosa, A., Simitakou, M. K., Arthur, C. J., Mulholland, A. J., Cherepanov, P., & Raven, E. L. (2023). Heme binding to the SARS-CoV-2 spike glycoprotein. Journal of Biological Chemistry, 299(8), 105014. https://doi.org/10.1016/j.jbc.2023.105014
Vancouver
Freeman SL, Oliveira ASF, Gallio AE, Rosa A, Simitakou MK, Arthur CJ, et al. Heme binding to the SARS-CoV-2 spike glycoprotein. Journal of Biological Chemistry. 2023;299(8):105014. doi:10.1016/j.jbc.2023.105014
BibTeX
@article{Freeman2023,
author = {Freeman, Samuel L and Oliveira, A Sofia F and Gallio, Andrea E and Rosa, Annachiara and Simitakou, Maria K and Arthur, Christopher J and Mulholland, Adrian J and Cherepanov, Peter and Raven, Emma L},
title = {Heme binding to the SARS-CoV-2 spike glycoprotein},
journal = {Journal of Biological Chemistry},
year = {2023},
volume = {299},
number = {8},
pages = {105014},
doi = {10.1016/j.jbc.2023.105014}
}
EUVIMED